AET and finished dosage forms. At the service of international healthcare systems.
Building on its successes as an agent for renowned API producers, AET expanded into the rapidly developing market for generics in the 1990s. Today, with its far-reaching expertise, AET counts among the leading European corporations in the backwardly integrated generics development sector.
At AET Labs, and with selected international partners, AET develops tailor-made products – beginning with development via documentation and registration through to production, packaging and just-in-time delivery. The commissioners also profit from the knowledge and experience of AET in sustained marketing of a generic. Directly after the successful launch of a product, AET marketing experts examine its future chances and growth potential in the regional markets. From this they develop applicable strategies for the entire supply chain, in order to sustainably secure the life cycle of the product.